ZYME
Zymeworks Inc.
26.60$
-3.3%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.7% | 76.4% | 49.5% | 70.0% | 83.6% | 84.7% | 84.5% | 74.1% | 84.0% | 71.1% | 64.9% | 67.4% | |
| 92.4% | 49.8% | 17.5% | 27.2% | 17.3% | 34.9% | 45.0% | 51.9% | 61.8% | 27.1% | 14.3% | 11.9% | |
| 92.4% | 65.5% | 42.8% | 66.5% | 81.9% | 81.2% | 79.2% | 64.9% | 75.9% | 64.4% | 48.8% | 66.0% | |
| 6.0% | 9.8% | 4.6% | 1.8% | 0.1% | 0.6% | 2.8% | 4.0% | 5.1% | 3.4% | 12.1% | 1.3% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | 0.0% | – | – | |
| 1.0% | 3.4% | 7.2% | 5.4% | 2.7% | 4.5% | 2.3% | 5.9% | 7.3% | – | – | – | |
| – | – | 12.8% | 9.1% | 4.9% | 3.3% | 2.2% | 3.1% | 1.9% | 2.1% | 2.6% | 3,467.6% | |
| 0.3% | 0.6% | 21.9% | 14.5% | 8.2% | 6.4% | 4.3% | 5.5% | 4.1% | 4.4% | 1.0% | 389.6% | |
| 21.5% | 21.2% | 90.4% | 11.8% | 26.1% | 33.3% | 23.9% | 36.0% | 24.0% | 20.0% | 26.8% | 22.5% | |
| 21.5% | 21.0% | 17.6% | 11.1% | 12.3% | 22.4% | 15.9% | 18.5% | 14.7% | 9.6% | 19.1% | 12.2% | |
| 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.3% | 0.5% | 0.3% | 0.5% | 0.7% | 0.6% | 1.0% | |
| 3.5% | 9.1% | 3.1% | 1.3% | 1.1% | 1.5% | 1.2% | 1.3% | 1.2% | 1.1% | 0.8% | 1.3% | |
| – | – | 4.7% | 0.0% | – | – | – | – | – | – | – | – | |
| 78.5% | 78.8% | 9.6% | 88.2% | -59.4% | 66.7% | 76.1% | 64.0% | 76.0% | 80.0% | 73.2% | 77.5% | |
| -88.3% | -276.1% | -104.0% | -82.4% | -59.4% | -79.0% | -87.5% | -175.5% | -86.1% | -116.6% | -179.3% | -275.1% | |
| 39.1% | 85.7% | 21.0% | 16.2% | 11.9% | 10.3% | 9.4% | 13.4% | 10.1% | 11.9% | 16.4% | 21.7% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.